On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- Introduction of resistance
- Drug discovery process
- Antibiotic resistance - two fundamental questions
- Mechanisms of antibiotic action
- Mechanisms of antibiotic resistance: efflux pumps
- Modification of the antibiotic pharmacophore
- Modification of the target structure
- Targeting existing therapy and resistance
- b-lactamase inhibition combined with antibiotic
- Avoiding efflux pump mechanisms
- Overcoming modification in the target structure (1)
- Overcoming modification in the target structure (2)
- Considerations and methods
- Factors for consideration: target (genomic) based
- Factors for consideration: whole cell based
- Target (genomic) based approaches
- "HIT" or "lead" discovery approaches
- Fragment based drug discovery
- HTS vs. fragment based approach
- Modelling: ligand and structure known approach
- The development of benzoylaminobenzolic acids
- Modelling: structure known but ligand unknown
- Discovery of bacterial MurD and MurE inhibitors
- Modelling: ligand known but structure unknown
- Virtual screening efforts
- Target (genomic) based approaches: summary
- Whole cell (empirical) based approaches
- Selection of chemical starting points (1)
- Selection of chemical starting points (2)
- Discovery of a new class of anti-TB agent (1)
- Discovery of a new class of anti-TB agent (2)
- Whole cell based approaches: summary
- General summary
Topics Covered
- Overview of the drug discovery process
- Mechanisms of antibiotic action and resistance
- Modification of the antibiotic pharmacophore
- Modification of the target structure
- Targeting existing therapy and resistance mechanisms
- Overcoming modification in the target structure
- Considerations and methods in the discovery of new antibiotics
- Genomic based approaches
- Lead discovery approaches
- Fragment based drug discovery
- Modelling: ligand and structure known approach
- Modelling: structure known but ligand unknown approach
- Modelling: ligand known but structure unknown
- Whole cell (empirical) based approaches
- Selection of chemical starting points
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Coxon, G. (2009, December 31). Medicinal chemistry strategies in combating antibiotic resistance [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/JESX5069.Export Citation (RIS)
Publication History
- Published on December 31, 2009
Financial Disclosures
- Dr. Geoffrey Coxon has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.